Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

2(40.0%)

5Total

N/A(3)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04322136Not ApplicableCompleted

AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion

Role: collaborator

NCT05340582Phase 2Recruiting

Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants

Role: collaborator

NCT05034367Not ApplicableCompleted

Reference Ranges for the Cough Responsiveness to Inhaled Mannitol

Role: collaborator

NCT06148051Recruiting

AusCADASIL: An Australian Cohort of CADASIL

Role: collaborator

NCT05184101Phase 2Withdrawn

Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19)

Role: collaborator

NCT02939586Not ApplicableCompleted

The Effect of Haemodialysis in Sleep Apnoea

Role: lead

NCT01279928Completed

Detection of Vascular Injury in Diabetes Through Eye and Nailfold Data (DIVIDEND) - A Pilot Study

Role: lead

All 7 trials loaded